0
     

Report Added
Report already added
Patient Access /Front-end RCM Solutions Market by Product & Service (Training, Education, Medical Necessity, Pre-certification), Delivery Mode (Web & Cloud, On premise), End User (Providers, Healthcare BPO Service Providers) - Global Forecast to 2027

Patient Access /Front-end RCM Solutions Market by Product & Service (Training, Education, Medical Necessity, Pre-certification), Delivery Mode (Web & Cloud, On premise), End User (Providers, Healthcare BPO Service Providers) - Global Forecast to 2027

The global patient access solutions market is projected to reach USD 2.9 billion by 2027 from an estimated USD 1.9 billion in 2022, at a CAGR of 8.9% during the forecast period. Growth in this market is driven by the growing government initiatives to support the HCIT solutions, increasing patient pool, increasing demand for health insurance, and the growing need to curtail healthcare costs. However, lack of skilled IT professionals & high deployment costs are expected to restrain the growth of this market to a certain extent.

“The web & cloud- based solutions segment is projected to be the largest segment & register the highest growth in the patient access solutions market, by application”

Based on application, the data aggregation segment is projected to be the largest segment & register the highest growth during the forecast period. Factors responsible for the growth of this segment are the advantages offered by the solutions such as on-demand self-serving analytics, no upfront capital investment for hardware, extreme capacity flexibility, and the pay-as-you-go pricing model.

“Healthcare Providers was the largest segment by the end user of patient access solutions market in 2021”

Healthcare providers segment is projected to grow at the highest growth rate in the patient access solutions market in 2021. The increasing demand for standardizing patient data, large amounts of healthcare data generated, increasing focus on patient safety, significant growth in healthcare spending, rising medical error rates, growing denials, increasing healthcare costs is expected to drive the demand for patient access solutions services in the coming years.

“APAC to witness the highest growth rate during the forecast period.”

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as the improving healthcare infrastructure, rising healthcare insurance coverage, and growing medical tourism.

The break-down of primary participants is as mentioned below:
•By Company Type - Tier 1: 42%, Tier 2: 31%, and Tier 3: 27%
•By Designation - C-level: 30%, Director-level: 45%, and Others: 25%
•By Region - North America: 42%, Europe: 28%, Asia Pacific: 19%, Latin America: 9%, and Middle East & Africa: 2%.

Key players in the Patient access solutions Market
The key players operating in the patient access solutions market include Cognizant (US), McKesson Corporation (US), Cerner Corporation (US), Experian Plc (Ireland), 3M (US), Conifer Health Solutions (US), Waystar (US), Epic Systems Corporation (US), The SSI Group, LLC (US), Optum, Inc. (US), Cirius Group, Inc. (US), Craneware, Inc. (Scotland), Allscripts Healthcare Solutions, Inc. (US), Genentech, Inc. (US).

Research Coverage:
The report analyzes the patient access solutions market and aims to estimate the market size and future growth potential of various market segments, based on product & service, delivery mode, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market.
Table of Contents

1INTRODUCTION24
1.1STUDY OBJECTIVES24
1.2MARKET DEFINITION24
1.2.1INCLUSIONS AND EXCLUSIONS24
1.3MARKETS COVERED25
FIGURE 1PATIENT ACCESS SOLUTIONS MARKET25
FIGURE 2REGIONAL SEGMENTS COVERED25
1.3.1YEARS CONSIDERED26
1.4CURRENCY CONSIDERED26
TABLE 1STANDARD CURRENCY CONVERSION RATES26
1.5STAKEHOLDERS27
1.6LIMITATIONS27
1.7SUMMARY OF CHANGES27
2RESEARCH METHODOLOGY29
2.1RESEARCH DATA29
FIGURE 3RESEARCH DESIGN29
2.1.1SECONDARY DATA29
2.1.1.1Key data from secondary sources31
2.1.2PRIMARY DATA32
FIGURE 4PRIMARY SOURCES32
2.1.2.1Key data from primary sources33
2.1.2.2Key industry insights33
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION34
2.2MARKET SIZE ESTIMATION34
FIGURE 6MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS35
FIGURE 7REVENUE SHARE ANALYSIS ILLUSTRATION35
FIGURE 8COUNTRY-LEVEL ANALYSIS OF PATIENT ACCESS SOLUTIONS MARKET36
FIGURE 9TOP-DOWN APPROACH36
FIGURE 10CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS38
FIGURE 11CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022-2027)38
2.3MARKET BREAKDOWN AND DATA TRIANGULATION39
FIGURE 12MARKET DATA TRIANGULATION METHODOLOGY39
2.4RESEARCH ASSUMPTIONS40

3EXECUTIVE SUMMARY41
FIGURE 13PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)41
FIGURE 14PATIENT ACCESS SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)42
FIGURE 15PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION)42
FIGURE 16PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)43
FIGURE 17GEOGRAPHICAL SNAPSHOT OF PATIENT ACCESS SOLUTIONS MARKET, 202144
4PREMIUM INSIGHTS45
4.1PATIENT ACCESS SOLUTIONS: MARKET OVERVIEW45
FIGURE 18GROWING IMPORTANCE OF DENIALS MANAGEMENT TO DRIVE MARKET45
4.2ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE AND END USER (2021)46
FIGURE 19WEB & CLOUD-BASED SOLUTIONS SEGMENT TO DOMINATE MARKET IN 202146
4.3PATIENT ACCESS SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES47
FIGURE 20UK TO REGISTER HIGHEST GROWTH IN MARKET DURING FORECAST PERIOD47
4.4REGIONAL MIX: PATIENT ACCESS SOLUTIONS MARKET (2022−2027)48
FIGURE 21NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD48
5MARKET OVERVIEW49
5.1INTRODUCTION49
5.2MARKET DYNAMICS49
FIGURE 22PATIENT ACCESS SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES49
5.2.1DRIVERS50
5.2.1.1Stringent government regulations for accessing patient data50
5.2.1.2Increasing patient volume and subsequent growth in demand for health insurance51
FIGURE 23GROWTH IN GERIATRIC POPULATION, BY REGION, 2015–205051
FIGURE 24PROJECTED HEALTHCARE SPENDING IN DIFFERENT REGIONS, 2017–2022 (USD BILLION)51
5.2.1.3Growing importance of denials management52
5.2.1.4Declining reimbursement rates52
5.2.1.5Rising need to curtail healthcare costs52
TABLE 2IMPACT ANALYSIS: MARKET DRIVERS53
5.2.2RESTRAINTS53
5.2.2.1Data breaches and loss of confidentiality53
TABLE 3LARGEST HEALTHCARE DATA BREACHES GLOBALLY (2020)54
TABLE 4IMPACT ANALYSIS: MARKET RESTRAINTS55
5.2.3OPPORTUNITIES55
5.2.3.1High growth potential in emerging healthcare IT markets55
TABLE 5IMPACT ANALYSIS: MARKET OPPORTUNITIES56
5.2.4CHALLENGES56
5.2.4.1Dearth of skilled healthcare IT professionals56
5.2.4.2Reluctance to adopt patient access solutions56
5.2.4.3High deployment costs57
TABLE 6IMPACT ANALYSIS: MARKET CHALLENGES57
6INDUSTRY INSIGHTS58
6.1INTRODUCTION58
TABLE 7ESTIMATED SPENDING ON REGULATORY COMPLIANCE BY HEALTHCARE PROVIDERS IN US58
6.2US: CURRENT SCENARIO OF HEALTHCARE CLAIMS MANAGEMENT58
6.2.1MANUAL VS. ELECTRONIC CLAIMS MANAGEMENT PROCESSES58
TABLE 8AVERAGE COST PER TRANSACTION FOR MANUAL AND ELECTRONIC TRANSACTIONS AND SAVINGS OPPORTUNITY, 201859
TABLE 9AVERAGE, MINIMUM, AND MAXIMUM TIME SPENT BY PROVIDERS CONDUCTING MANUAL AND ELECTRONIC TRANSACTIONS, 201860
6.2.2LACK OF STANDARDIZATION BETWEEN PAYER POLICIES60
6.3US: ADOPTION TRENDS FOR PATIENT ACCESS SOLUTIONS61
FIGURE 25US: ADOPTION AND VOLUME OF ELECTRONIC ELIGIBILITY AND BENEFIT VERIFICATIONS FOR COMMERCIAL MEDICAL HEALTH PLANS AND PROVIDERS61
6.4PATIENT ACCESS SOLUTIONS AND VALUE-BASED CARE62
FIGURE 26VALUE-BASED CARE THROUGH EFFICIENT DATA EXCHANGE62
6.5HCIT EXPENDITURE ANALYSIS63
6.5.1NORTH AMERICA63
FIGURE 27US HEALTHCARE SPENDING, 2012–2020 (USD BILLION)63
6.5.2EUROPE64
6.5.3ASIA PACIFIC64
6.6US: HCIT ADOPTION TRENDS64
FIGURE 28US: HOSPITAL EHR ADOPTION, 2007–201865
6.7REGULATORY ANALYSIS65
6.7.1NORTH AMERICA65
6.7.1.1US65
6.7.1.2Canada66
6.7.2EUROPE67
6.7.3ASIA PACIFIC68
6.8INDUSTRY TRENDS69
6.8.1GROWING FOCUS ON INTEGRATION PLATFORM AS A SERVICE (IPAAS)69
6.8.2BUDGETARY CONSTRAINTS AND COST-CUTTING MEASURES IN EUROPE69
6.9ECOSYSTEM ANALYSIS70
FIGURE 29MARKET ECOSYSTEM: PATIENT ACCESS SOLUTIONS MARKET70
6.10TECHNOLOGY ANALYSIS71
FIGURE 30FOCUS ON USING PATIENT ACCESS SOLUTIONS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT71
7PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE72
7.1INTRODUCTION73
TABLE 10PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)73
7.2SERVICES73
TABLE 11PATIENT ACCESS SOLUTIONS MARKET BY SERVICES, BY TYPE, 2020–2027 (USD MILLION)74
TABLE 12PATIENT ACCESS SOLUTIONS MARKET BY SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)74
7.2.1SUPPORT & MAINTENANCE SERVICES75
7.2.1.1Rising trend of outsourcing to drive segment75
TABLE 13SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)75
7.2.2IMPLEMENTATION SERVICES76
7.2.2.1Increasing adoption of software by healthcare providers to fuel segment76
FIGURE 31ADOPTION OF ELECTRONIC ADMINISTRATIVE TRANSACTIONS, 2018–202176
TABLE 14IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)77
7.2.3TRAINING & EDUCATION SERVICES77
7.2.3.1Training & education services to increase healthcare providers’ awareness about available patient access solutions77
TABLE 15TRAINING & EDUCATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)78
7.3SOFTWARE78
TABLE 16PATIENT ACCESS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)79
TABLE 17PATIENT ACCESS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)79
7.3.1ELIGIBILITY VERIFICATION SOFTWARE80
7.3.1.1Real-time access to healthcare payers to propel segment80
FIGURE 32ADOPTION OF ELECTRONIC ELIGIBILITY AND BENEFIT VERIFICATION, 2019–202180
TABLE 18KEY PLAYERS PROVIDING ELIGIBILITY VERIFICATION SOFTWARE80
TABLE 19ELIGIBILITY VERIFICATION SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)81
7.3.2MEDICAL NECESSITY MANAGEMENT SOFTWARE81
7.3.2.1Accelerated cash flow and net revenue to drive segment81
TABLE 20KEY PLAYERS PROVIDING MEDICAL NECESSITY MANAGEMENT SOFTWARE82
TABLE 21MEDICAL NECESSITY MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)82
7.3.3PRECERTIFICATION & AUTHORIZATION SOFTWARE83
7.3.3.1Cost efficiency and management of real-time authorization requests to fuel segment83
TABLE 22KEY PLAYERS PROVIDING PRECERTIFICATION & AUTHORIZATION SOFTWARE83
TABLE 23PRECERTIFICATION & AUTHORIZATION SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)84
7.3.4CLAIMS DENIAL & APPEAL MANAGEMENT SOFTWARE84
7.3.4.1Streamlined productivity tools and claims-related alerts to fuel segment84
TABLE 24KEY PLAYERS PROVIDING CLAIMS DENIAL & APPEAL MANAGEMENT SOFTWARE85
TABLE 25CLAIMS DENIAL & APPEAL MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)85
7.3.5PAYMENT ESTIMATION SOFTWARE86
7.3.5.1Need to control rising healthcare costs to drive segment86
TABLE 26KEY PLAYERS PROVIDING PAYMENT ESTIMATION SOFTWARE86
TABLE 27PAYMENT ESTIMATION SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)86
7.3.6CLAIMS PAYMENT ASSESSMENT & PROCESSING SOFTWARE87
7.3.6.1Increasing government initiatives to propel segment87
TABLE 28KEY PLAYERS PROVIDING CLAIMS PAYMENT ASSESSMENT & PROCESSING SOFTWARE87
TABLE 29CLAIMS PAYMENT ASSESSMENT & PROCESSING SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)88
7.3.7OTHER SOFTWARE88
TABLE 30OTHER SOFTWARE MARKET FOR PATIENT ACCESS SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)89
8PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE90
8.1INTRODUCTION91
TABLE 31PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)91
8.2WEB & CLOUD-BASED SOLUTIONS91
8.2.1COST-EFFECTIVENESS AND LARGE STORAGE CAPACITY TO PROPEL MARKET91
TABLE 32PATIENT ACCESS SOLUTIONS MARKET FOR WEB & CLOUD-BASED SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)92
8.3ON-PREMISE SOLUTIONS92
8.3.1REDUCED RISK OF DATA BREACHES AND OTHER SECURITY ISSUES TO DRIVE MARKET92
TABLE 33PATIENT ACCESS SOLUTIONS MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)93
9PATIENT ACCESS SOLUTIONS MARKET, BY END USER94
9.1INTRODUCTION95
TABLE 34PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)95
9.2HEALTHCARE PROVIDERS96
9.2.1HEALTHCARE PROVIDERS TO DOMINATE MARKET DURING FORECAST PERIOD96
TABLE 35PATIENT ACCESS SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)97
9.3HCIT OUTSOURCING COMPANIES97
9.3.1HCIT OUTSOURCING COMPANIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD97
TABLE 36PATIENT ACCESS SOLUTIONS MARKET FOR HCIT OUTSOURCING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)98
9.4OTHER END USERS98
TABLE 37PATIENT ACCESS SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)99
10PATIENT ACCESS SOLUTIONS MARKET, BY REGION100
10.1INTRODUCTION101
TABLE 38PATIENT ACCESS SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)101
10.2NORTH AMERICA101
FIGURE 33NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET SNAPSHOT, 2021102
TABLE 39NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)103
TABLE 40NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)103
TABLE 41NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)103
TABLE 42NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)104
TABLE 43NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)104
TABLE 44NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)105
10.2.1US105
10.2.1.1Growing need to curtail healthcare costs to drive market105
TABLE 45US: KEY MACROINDICATORS106
TABLE 46US: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)107
TABLE 47US: PATIENT ACCESS SOLUTIONS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)107
TABLE 48US: PATIENT ACCESS SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 49US: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)108
TABLE 50US: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)109
10.2.2CANADA109
10.2.2.1Need for financial management in healthcare organizations to support market109
TABLE 51CANADA: KEY MACROINDICATORS110
TABLE 52CANADA: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)110
TABLE 53CANADA: PATIENT ACCESS SOLUTIONS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)111
TABLE 54CANADA: PATIENT ACCESS SOLUTIONS MARKET BY SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)111
TABLE 55CANADA: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)112
TABLE 56CANADA: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)112
10.3EUROPE112
TABLE 57EHEALTH PRIORITIES FOR HEALTHCARE PROVIDERS IN EUROPE, BY COUNTRY (2019)113
FIGURE 34EUROPE: EHEALTH CHALLENGES FACED BY HEALTHCARE PROVIDERS, 2019114
TABLE 58EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 59EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)115
TABLE 60EUROPE: PATIENT ACCESS SOLUTIONS MARKET BY SERVICES, BY TYPE, 2020–2027 (USD MILLION)115
TABLE 61EUROPE: PATIENT ACCESS SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)116
TABLE 62EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)116
TABLE 63EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)117
10.3.1GERMANY117
10.3.1.1Increasing government initiatives to boost market117
TABLE 64GERMANY: KEY MACROINDICATORS118
TABLE 65GERMANY: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)118
TABLE 66GERMANY: PATIENT ACCESS SOLUTIONS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)118
TABLE 67GERMANY: PATIENT ACCESS SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 68GERMANY: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)119
TABLE 69GERMANY: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)120
10.3.2FRANCE120
10.3.2.1Upcoming retirement of doctors to drive market120
TABLE 70FRANCE: KEY MACROINDICATORS121
TABLE 71FRANCE: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)121
TABLE 72FRANCE: PATIENT ACCESS SOLUTIONS MARKET BY SERVICES, BY TYPE, 2020–2027 (USD MILLION)121
TABLE 73FRANCE: PATIENT ACCESS SOLUTIONS MARKET BY SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)122
TABLE 74FRANCE: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)122
TABLE 75FRANCE: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)123
10.3.3UK123
10.3.3.1Government initiatives for EMR and eHealth solutions to drive market123
TABLE 76UK: KEY MACROINDICATORS124
TABLE 77UK: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)124
TABLE 78UK: PATIENT ACCESS SOLUTIONS MARKET BY SERVICES, BY TYPE, 2020–2027 (USD MILLION)124
TABLE 79UK: PATIENT ACCESS SOLUTIONS MARKET BY SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 80UK: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)125
TABLE 81UK: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)126
10.3.4REST OF EUROPE126
TABLE 82REST OF EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)127
TABLE 83REST OF EUROPE: PATIENT ACCESS SOLUTIONS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)127
TABLE 84REST OF EUROPE: PATIENT ACCESS SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)128
TABLE 85REST OF EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)128
TABLE 86REST OF EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)129
10.4ASIA PACIFIC129
10.4.1INCREASING NEED FOR IMPROVED FINANCIAL MANAGEMENT TO DRIVE MARKET129
FIGURE 35ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET SNAPSHOT, 2021130
TABLE 87ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)131
TABLE 88ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 89ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)132
TABLE 90ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)132
TABLE 91ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)133
10.5LATIN AMERICA133
10.5.1DEVELOPMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET133
TABLE 92LATIN AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)134
TABLE 93LATIN AMERICA: PATIENT ACCESS SOLUTIONS MARKET BY SERVICES, BY TYPE, 2020–2027 (USD MILLION)134
TABLE 94LATIN AMERICA: PATIENT ACCESS SOLUTIONS MARKET BY SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)135
TABLE 95LATIN AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)135
TABLE 96LATIN AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)136
10.6MIDDLE EAST & AFRICA136
10.6.1GROWING MEDICAL TOURISM TO SUPPORT MARKET136
TABLE 97MIDDLE EAST & AFRICA: PATIENT ACCESS SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)137
TABLE 98MIDDLE EAST & AFRICA: PATIENT ACCESS SOLUTIONS MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)137
TABLE 99MIDDLE EAST & AFRICA: PATIENT ACCESS SOLUTIONS MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION)138
TABLE 100MIDDLE EAST & AFRICA: PATIENT ACCESS SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)138
TABLE 101MIDDLE EAST & AFRICA: PATIENT ACCESS SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)139
11COMPETITIVE LANDSCAPE140
11.1INTRODUCTION140
TABLE 102KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM JANUARY 2019 TO JUNE 2022140
11.2PATIENT ACCESS SOLUTIONS MARKET: GEOGRAPHICAL ASSESSMENT141
FIGURE 36GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN PATIENT ACCESS SOLUTIONS MARKET (2021)141
11.3PATIENT ACCESS SOLUTIONS MARKET: R&D EXPENDITURE142
FIGURE 37R&D EXPENDITURE OF KEY PLAYERS IN PATIENT ACCESS SOLUTIONS MARKET (2021)142
11.4REVENUE ANALYSIS OF MARKET PLAYERS142
FIGURE 38REVENUE ANALYSIS: PATIENT ACCESS SOLUTIONS MARKET, 2021143
11.5MARKET SHARE ANALYSIS143
FIGURE 39PATIENT ACCESS SOLUTIONS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021143
11.6COMPETITIVE LEADERSHIP MAPPING144
11.6.1STARS144
11.6.2EMERGING LEADERS145
11.6.3PERVASIVE PLAYERS145
11.6.4PARTICIPANTS145
FIGURE 40PATIENT ACCESS SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)146
11.7COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)147
11.7.1PROGRESSIVE COMPANIES147
11.7.2RESPONSIVE COMPANIES147
11.7.3DYNAMIC COMPANIES147
11.7.4STARTING BLOCKS147
FIGURE 41PATIENT ACCESS SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2021)148
11.8COMPETITIVE BENCHMARKING149
FIGURE 42ANALYSIS OF PRODUCT & SERVICE PORTFOLIOS OF MAJOR PLAYERS IN PATIENT ACCESS SOLUTIONS MARKET149
FIGURE 43BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN PATIENT ACCESS SOLUTIONS MARKET150
11.9COMPETITIVE SITUATIONS AND TRENDS151
11.9.1DEALS151
TABLE 103DEALS (2019–2022)151
12COMPANY PROFILES152
12.1KEY PLAYERS152
(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View)*
12.1.1MCKESSON CORPORATION152
TABLE 104MCKESSON CORPORATION: COMPANY OVERVIEW152
FIGURE 44MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)153
12.1.2OPTUM, INC.155
TABLE 105OPTUM, INC.: COMPANY OVERVIEW155
FIGURE 45OPTUM, INC.: COMPANY SNAPSHOT (2021)155
12.1.3COGNIZANT158
TABLE 106COGNIZANT: COMPANY OVERVIEW158
FIGURE 46COGNIZANT: COMPANY SNAPSHOT (2021)159
12.1.4CERNER CORPORATION162
TABLE 107CERNER CORPORATION: COMPANY OVERVIEW162
FIGURE 47CERNER CORPORATION: COMPANY SNAPSHOT (2021)163
12.1.5EXPERIAN PLC166
TABLE 108EXPERIAN PLC: COMPANY OVERVIEW166
FIGURE 48EXPERIAN PLC: COMPANY SNAPSHOT (2021)167
12.1.63M169
TABLE 1093M: COMPANY OVERVIEW169
FIGURE 493M: COMPANY SNAPSHOT (2021)170
12.1.7CONIFER HEALTH SOLUTIONS171
TABLE 110CONIFER HEALTH SOLUTIONS: COMPANY OVERVIEW171
FIGURE 50CONIFER HEALTH SOLUTIONS: COMPANY SNAPSHOT (2021)171
12.1.8CRANEWARE, INC.173
TABLE 111CRANEWARE, INC.: COMPANY OVERVIEW173
FIGURE 51CRANEWARE, INC.: COMPANY SNAPSHOT (2021)173
12.1.9GENENTECH, INC. (ROCHE)175
TABLE 112GENENTECH, INC.: COMPANY OVERVIEW175
FIGURE 52ROCHE: COMPANY SNAPSHOT (2021)176
12.1.10ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.177
TABLE 113ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY OVERVIEW177
FIGURE 53ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2021)178
12.1.11EPIC SYSTEMS CORPORATION180
TABLE 114EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW180
12.1.12WAYSTAR181
TABLE 115WAYSTAR: COMPANY OVERVIEW181
12.1.13THE SSI GROUP, LLC183
TABLE 116THE SSI GROUP, LLC: COMPANY OVERVIEW183
12.1.14CIRIUS GROUP, INC.184
TABLE 117CIRIUS GROUP, INC.: COMPANY OVERVIEW184
12.1.15ACCUREG SOFTWARE185
TABLE 118ACCUREG SOFTWARE: COMPANY OVERVIEW185
* Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12.2OTHER PLAYERS186
12.2.1PATIENT ACCESS SOLUTIONS, INC.186
12.2.2KYRUUS186
12.2.3EXELA TECHNOLOGIES, INC.187
12.2.4ACCESS ONE, INC.187
12.2.5VEE TECHNOLOGIES188
12.2.6CONDUENT, INC.188
12.2.7FINTHRIVE189
12.2.8PLEXIS HEALTHCARE SYSTEMS189
12.2.9HEALTHASYST190
12.2.10VIRTUSA CORPORATION190
13APPENDIX191
13.1DISCUSSION GUIDE191
13.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL195
13.3AVAILABLE CUSTOMIZATION OPTIONS197
13.4RELATED REPORTS197
13.5AUTHOR DETAILS198

Report Title: Patient Access /Front-end RCM Solutions Market by Product & Service (Training, Education, Medical Necessity, Pre-certification), Delivery Mode (Web & Cloud, On premise), End User (Providers, Healthcare BPO Service Providers) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM